Sawyer & Company Inc Reduces Holdings in Colgate-Palmolive (NYSE:CL)

Sawyer & Company Inc reduced its holdings in shares of Colgate-Palmolive (NYSE:CL) by 3.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,441 shares of the company’s stock after selling 563 shares during the period. Sawyer & Company Inc’s holdings in Colgate-Palmolive were worth $1,300,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in CL. Vest Financial LLC raised its holdings in Colgate-Palmolive by 25.1% in the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after purchasing an additional 74,337 shares during the period. Central Bank & Trust Co. lifted its position in shares of Colgate-Palmolive by 22.1% during the 4th quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock valued at $110,000 after buying an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC grew its stake in shares of Colgate-Palmolive by 9.2% during the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock valued at $864,000 after acquiring an additional 910 shares during the period. Sarasin & Partners LLP increased its holdings in Colgate-Palmolive by 1.2% in the 4th quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after acquiring an additional 49,980 shares in the last quarter. Finally, Cornerstone Wealth Management LLC raised its stake in Colgate-Palmolive by 2.5% during the 4th quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock worth $571,000 after acquiring an additional 172 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $96.99 on Friday. The firm has a market capitalization of $79.57 billion, a PE ratio of 30.69, a PEG ratio of 3.61 and a beta of 0.39. The stock’s fifty day moving average is $93.87 and its 200 day moving average is $87.51. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $99.08. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.70 and a current ratio of 1.06.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The business had revenue of $5.07 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter in the prior year, the firm posted $0.73 earnings per share. The business’s revenue for the quarter was up 6.2% on a year-over-year basis. On average, sell-side analysts anticipate that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.06%. Colgate-Palmolive’s payout ratio is 63.29%.

Analyst Upgrades and Downgrades

CL has been the subject of a number of recent analyst reports. Citigroup upped their price target on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, April 16th. Bank of America upped their target price on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, April 29th. Argus raised their price target on Colgate-Palmolive from $97.00 to $107.00 and gave the company a “buy” rating in a report on Wednesday, May 15th. The Goldman Sachs Group assumed coverage on Colgate-Palmolive in a research note on Friday, March 1st. They issued a “buy” rating and a $93.00 price objective for the company. Finally, Stifel Nicolaus lifted their target price on Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, April 29th. Three analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $93.83.

Insider Transactions at Colgate-Palmolive

In other news, insider John W. Kooyman sold 3,497 shares of Colgate-Palmolive stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares in the company, valued at $297,328.07. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the transaction, the insider now directly owns 13,924 shares in the company, valued at approximately $1,309,691.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider John W. Kooyman sold 3,497 shares of the company’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the sale, the insider now owns 3,181 shares of the company’s stock, valued at $297,328.07. The disclosure for this sale can be found here. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.